Uveitis: Symptoms, Red Flags & Specialist Referral

Uveitis describes a heterogeneous group of inflammatory disorders in which leukocytes infiltrate the uveal structures. The Standardization of Uveitis Nomenclature (SUN) Working Group framework partitions disease by the primary site of inflammation into anterior, intermediate, posterior and panuveitis, which correlates with symptom clusters, systemic associations and threat to vision. Anterior uveitis (iritis/iridocyclitis) localises to the iris and pars plana anterior to the vitreous base; intermediate uveitis centres on the vitreous; posterior uveitis targets the choroid or retina; panuveitis involves all compartments.

Pathophysiology is not a single pathway: autoinflammatory, autoimmune, trauma-associated, drug-induced and infectious processes converge on breakdown of blood–ocular barrier integrity, cytokine release (TNF-α, IL-6, IL-17 among others) and recruitment of inflammatory cells into the anterior chamber or vitreous. The clinical implication is that two patients labelled “uveitis” may require opposite therapeutic vectors—one needs intensive topical steroids for HLA-B27–linked anterior flares while another needs antiviral or anti-tuberculous therapy for necrotising retinitis.

Nursing and ward teams most often encounter patients during initial flare, during systemic immunosuppression titration, or when they re-present with pain or vision change between scheduled ophthalmology visits. Understanding the anatomic class and treatment phase is what allows meaningful vital-sign and symptom trending, safer pre-assessment before dilation, and accurate routing to ophthalmology versus emergency services.

Use SUN terminology in handoffs—mixing “iritis” and “posterior uveitis” loosely obscures risk. Slit-lamp grading of anterior chamber (AC) cells and flare gives objective anchors for response; document the grade the ophthalmologist states rather than inventing numbers if you are not certified to grade.

↔On a small screen, swipe or scroll sideways to see the full table.

AC cell grades run from 0 (none) to 4+ (severe) in half-log steps on standardised SUN scales; flare grades similarly reflect protein leakage. A one-step worsening after apparent improvement should trigger same-day ophthalmology communication even if the patient still “looks comfortable” with oral analgesia.

Anterior flares classically produce unilateral deep ache, intense photophobia and circumlimbal injection—pain typically worsens with accommodation because of ciliary spasm. Patients may report mild blurred vision from inflammatory debris or secondary corneal oedema rather than primary retinal pathology. Intermediate uveitis more often presents with painless floaters and slowly progressive vision decline in younger adults, sometimes linked to multiple sclerosis work-up. Posterior segment inflammation may be silent until central involvement causes abrupt reading difficulty or a relative afferent pupillary defect when optic nerve inflammation co-exists.

Who presents atypically?

Children with chronic anterior uveitis tied to juvenile idiopathic arthritis may have white, quiet eyes—screening relies on scheduled slit-lamp surveillance, not symptoms. Older adults or travellers may present with infectious masquerades (syphilis, tuberculosis, toxoplasmosis). Immunosuppressed hosts can develop fulminant necrotising retinitis with minimal external redness; any new floaters plus immunosuppression should be treated as time-critical.

Idiopathic inflammation remains common, but always consider systemic immune disease and infection before anchoring on “autoimmune uveitis”. HLA-B27–positive ankylosing spondylitis spectrum disease is a dominant association for acute recurrent anterior uveitis. Rheumatoid arthritis itself uncommonly causes uveitis but patients may be on steroids or biologics that mask infection. Lupus can produce retinal vasculitis or serous detachments overlapping uveitic patterns.

Infectious triggers include herpetic disease, syphilis, tuberculosis, toxoplasmosis, and endogenous endophthalmitis; shingles with keratouveitis is a classic unilateral painful presentation. Medication-induced uveitis (immune checkpoint inhibitors, rifabutin, some chemotherapeutics) should be reconciled on every admission medication review. Trauma, intraocular surgery and retained lens matter can incite sterile or infectious inflammation.

Any patient describing curtain-like vision loss with photopsiae needs retinal detachment excluded urgently—see Related Library for retinal detachment when counselling on red-flag symptoms.

Clinical assessment

Visual acuity with pinhole, pupil size and symmetry, basic confrontation fields if trained, and measurement of IOP when authorised are the ward-level bundle before ophthalmology slit-lamp biomicroscopy. Document pain scores and photophobia severity—they track treatment response faster than acuity in some anterior flares.

Laboratory investigations

Ophthalmology and rheumatology select targeted labs: syphilis serology, quantiferon/IGRA or tuberculin testing guided by risk, ACE/lymphocyte subsets only when sarcoidosis is plausible, HIV serology when panuveitis or opportunistic morphology appears. FBC, renal and liver panels support methotrexate or cyclosporine safety.

Imaging

Optical coherence tomography, fundus photography, fluorescein angiography and B-scan ultrasound are specialist-led; nurses facilitate timely transport, dilation counselling and glucose checks when systemic steroids are planned.

1. Identify painful photophobic red eye versus painless injection—route urgency.
2. Check vision and pupils; new RAPD or severe acuity drop → emergency ophthalmology.
3. Flag immunosuppression, HIV risk, pregnancy, or recent intraocular surgery.
4. Hold topical anaesthetic; shield eye; arrange same-day specialist review.
5. After ophthalmology diagnosis, align nursing observations with steroid taper chart and IOP schedule.
6. Biologic pathway: confirm TB screen, LFTs/FBC baseline, vaccination documentation.

Conjunctivitis shows superficial injection maximal in fornices, little true photophobia, and watery or mucopurulent discharge without fine KP. Acute angle-closure produces corneal steaminess and rock-hard IOP. Keratitis may stain with fluorescein. Multiple sclerosis-associated intermediate uveitis may be painless—do not dismiss floaters in young women with prior neurological events.

Ophthalmologists titrate topical steroids (commonly dexamethasone or prednisolone acetate drops) and long-acting cycloplegics to relieve ciliary spasm and limit synechiae. Periocular or oral prednisone / methylprednisolone pulses are used for severe bilateral or posterior disease. Steroid-sparing immunomodulators include methotrexate, mycophenolate, tacrolimus and biologics such as adalimumab or infliximab for refractory uveitis associated with ankylosing spondylitis or Behçet-like courses per multidisciplinary plans.

Infectious aetiologies receive pathogen-specific antimicrobials; never start prolonged topical steroids alone when infectious panuveitis remains plausible. Macular oedema may require intravitreal or systemic therapy decided solely in specialist settings.

Pregnancy limits oral teratogens—only specialist-directed regimens. Children with JIA need prolonged surveillance even when joints are quiet. Older adults may have steroid-induced glaucoma or psoriasis flares when systemic immunosuppression is tapered—communicate skin and joint symptoms to rheumatology.

Align nursing documentation with SUN class once known. Reconcile every admission against topical steroid drops—patients may use multiple bottles with different potencies. Coordinate dilating drops only per protocol because driving restrictions and narrow-angle risk matter. For tuberculosis-endemic exposure histories, ensure IGRA results are filed before first infliximab infusion where biologics are planned jointly with rheumatology.

• Visual acuity each shift if inpatient; log pain and photophobia scores.
• Check blood glucose on induction doses of systemic steroids if diabetic.
• Monitor BP and mood on high-dose oral steroids; escalate mood crisis per local policy.
• Confirm methotrexate labs before each cycle when shared-care charts specify dates.
• Teach punctal occlusion after drops if systemic beta-blocker risk is relevant.

Persistent inflammation causes cataract, band keratopathy (especially in children), cystoid macular oedema, glaucoma from trabeculitis or steroid response, hypotony from ciliary shutdown, and epiretinal membrane formation. Chronic steroid exposure adds infection vulnerability—coach patients on early fever reporting while on combined oral agents and biologics.

There is no vaccine for idiopathic uveitis; prevention is secondary—strict adherence to steroid taper, early return for symptom recurrence, control of systemic inflammation in ulcerative colitis and spondyloarthritis, and travel-aware screening for TB before biologics. Eye protection reduces trauma-associated inflammation.

Isolated HLA-B27 anterior uveitis often relapses but responds to topical therapy with good acuity if IOP monitored. Intermediate uveitis may run a chronic indolent course requiring systemic immunomodulation. Infectious retinitis portends poor outcomes without rapid antiviral or anti-TB therapy—prognosis hinges on time-to-treatment and baseline immune status.

Subtle deterioration

A “stable” patient who begins closing one eye to read, reports new-onset haloes, or needs increasing analgesia is deteriorating before acuity boxes change—phone ophthalmology with the objective trend.

Communication friction

Patients may equate red eye with self-limiting conjunctivitis; use plain language to explain why same-day specialist review is non-negotiable and that dark glasses do not treat inflammation.

Documentation

Photograph external eye only if policy permits; never delay transfer for photography. Record exact drop names, concentrations, and last dose time.

Initial bundle: ABCDE; shield affected eye; nil by mouth if theatre possible; avoid pilocarpine in undifferentiated painful red eye; mark time of last meal for anaesthesia; notify ophthalmology and infectious diseases when necrotising infection is suspected; document steroid and drop history.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response and matrix matching on the topic of uveitis triage, SUN anatomy, steroid stewardship, infectious masquerades and biologic safety—matched to Clinical Judgment Measurement Model reasoning from cue recognition through evaluation of outcomes.